Universe Pharmaceuticals (UPC) Change in Accured Expenses (2020 - 2024)

Universe Pharmaceuticals has disclosed Change in Accured Expenses across 5 years of filings, most recently posting $2.7 million for Q1 2024.

• Change in Accured Expenses for Q1 2024 came in at $2.7 million, up 26.35% year-over-year; the trailing twelve-month figure through Mar 2024 was $2.7 million (up 26.35% YoY), and the FY2025 annual result was -$85.4 million, down 171.52% from the prior year.
• Change in Accured Expenses came in at $2.7 million for Q1 2024 at Universe Pharmaceuticals, up from $2.7 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $376.0 billion in Q3 2020 to a low of $444319.0 in Q3 2021.
• The 5-year median for Change in Accured Expenses is $2.5 million (2022), against an average of $53.7 billion.
• Across the five-year window, Change in Accured Expenses slumped 100.0% in 2021 and surged 471.52% in 2022, its largest moves.
• Universe Pharmaceuticals' Change in Accured Expenses stood at $376.0 billion in 2020, then plunged by 100.0% to $444319.0 in 2021, then soared by 471.52% to $2.5 million in 2022, then rose by 6.79% to $2.7 million in 2023, then grew by 0.53% to $2.7 million in 2024.
• The last three Change in Accured Expenses figures came in at $2.7 million (Q1 2024), $2.7 million (Q3 2023), and $2.2 million (Q1 2023), per Business Quant data.